Estrella Immunopharma, INC S-1 registration statements

Estrella Immunopharma, Inc. filed an Amendment No. 2 to its S-1 Registration Statement, primarily updating exhibits, with its auditor noting a going concern issue.

Estrella Immunopharma, a clinical-stage biopharmaceutical company, filed an S-1/A to register shares for resale, highlighting ongoing clinical trial progress for EB103 and recent capital raises amidst significant operating losses and going concern doubts.

Estrella Immunopharma, a clinical-stage biopharmaceutical company, filed an S-1 registration statement for the resale of up to 2,541,206 shares of common stock by selling stockholders, while reporting continued operating losses and a going concern doubt.